# Product Facts - JPMorgan Healthcare Leaders ETF

> Audience: country=us, language=en, role=adv.
> Generated: 2026-10-08T23:21:25.339829745Z.

## Identity

- **Fund Name**: JPMorgan Healthcare Leaders ETF
- **Share Class Name**: JPMorgan Healthcare Leaders ETF
- **Product Page**: [Product Page](https://am.jpmorgan.com/us/en/asset-management/adv/products/jpmorgan-healthcare-leaders-etf-etf-shares-46654q765)
- **Ticker**: JDOC
- **CUSIP**: 46654Q765
- **Fund Type**: ETF
- **Asset Class**: International Equity
- **Fund Inception Date**: 11/01/2023
- **Investment Objective**: The Fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies ("Healthcare Companies") which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. The Fund will invest globally, including in both developed and emerging market countries, although it expects to invest a majority of its Assets in U.S. Healthcare Companies.

## Fund Facts

- **Ticker**: JDOC
- **CUSIP**: 46654Q765
- **Asset Class**: International Equity
- **Fund Inception Date**: 11/01/2023
- **Exchange**: NASDAQ
- **ESG Approach**: Integrated [Disclosure 1]

## Fund Stats

- **NAV  As of 10/08/2026**: $59.63
- **NAV Change ($) As of 10/08/2026**: $-0.45
- **NAV Change (%) As of 10/08/2026**: -0.76%
- **Non-Fair Value NAV  As of 10/08/2026**: $59.42 [Disclosure 2]
- **Closing Price  As of 10/08/2026**: $59.71
- **Closing Price Change ($) As of 10/08/2026**: $-0.44
- **Closing Price Change (%) As of 10/08/2026**: -0.76%
- **Discount/Premium As of 10/08/2026**: 0.14%
- **30 Day SEC Yield  As of 09/30/2026**: 0.83%
- **30 Day SEC Yield Unsubsidized As of 09/30/2026**: 0.83%
- **Dividend Yield As of 09/30/2026**: 0.85%
- **12-Month Rolling Dividend Yield As of 09/30/2026**: 0.89%
- **Daily - 30 Day SEC Yield As of 10/07/2026**: 0.83%
- **Daily - 30 Day SEC Yield Unsubsidized As of 10/07/2026**: 0.83%
- **Fund Assets As of 10/08/2026**: $8.94mn
- **Shares Outstanding As of 10/08/2026**: 150,000
- **Number of Holdings As of 10/07/2026**: 59
- **YTD  As of 10/08/2026**: 3.08%
- **Market Price Returns  As of 10/08/2026**: 3.22%

## Portfolio Managers

### Dominic Valder

- **In the industry**: 28 years
- **With J.P. Morgan**: 6 years
- **Managing this fund**: 3 years

### Bartjan van Hulten

- **In the industry**: 30 years
- **With J.P. Morgan**: 8 years
- **Managing this fund**: 2 years

## Documents

- [Factsheet: JPMorgan Healthcare Leaders ETF](https://am.jpmorgan.com/content/dam/jpm-am-aem/americas/us/en/literature/fact-sheet/etfs/FS-JDOC.PDF)
- [ETF Dividend Calendar 2026](https://am.jpmorgan.com/content/dam/jpm-am-aem/americas/us/en/supplemental/income-distribution-rates/jpmorgan-etfs-2026-distribution-notice.pdf)
- [Summary Prospectus](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/SP?site=JPMorganv3)
- [Prospectus](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/P?site=JPMorganv3)
- [Annual Report to Shareholders](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/AR?site=JPMorganv3)
- [Annual Financial Statements and Other Information](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/NCSR?site=JPMorganv3)
- [Semi-Annual Report to Shareholders](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/SAR?site=JPMorganv3)
- [Semi-Annual Financial Statements and Other Information](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/NCSRS?site=JPMorganv3)
- [First Quarter Holding](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/QH1?site=JPMorganv3)
- [Third Quarter Holding](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/QH3?site=JPMorganv3)
- [Statement of Additional Information](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/S?site=JPMorganv3)
- [Annual Report Of Proxy Voting](https://am.jpmorgan.com/JPMorgan/TVT/46654Q765/NPX?site=JPMorganv3)

## Disclosures

1. This Fund considers financially material environmental, social and governance ("ESG") factors as part of the Fund's investment process. In actively managed assets deemed by J.P. Morgan Asset Management to be ESG integrated under our governance process, we systematically assess financially material ESG factors amongst other factors in our investment decisions with the goals of managing risk and improving long-term returns. ESG integration does not change a strategy's investment objective, exclude specific types of companies or constrain a strategy's investable universe.

2. Non-Fair Value NAV: The published NAV includes adjustments made to prices of international stocks to compensate for price changes occurring after local markets close and exchange rates at the 4 PM New York close, the Non-Fair Value NAV excludes these price adjustments and uses exchange rates at the 4PM London close. Investors cannot transact at Non-Fair Value.